AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Analysts Bullish on Healthcare Stocks: Labcorp Holdings and Abivax SA Sponsored ADR
ByAinvest
Tuesday, Aug 26, 2025 6:05 pm ET1min read
Analysts at Bloomberg recommend buying Labcorp Holdings (LH) and Abivax SA Sponsored ADR (ABVX). Labcorp Holdings has a Strong Buy consensus rating with a $297.08 average price target, representing a 6.9% upside. Abivax SA Sponsored ADR also has a Strong Buy consensus rating with a $87.17 price target. Both companies have experienced bullish sentiments from analysts.
Analysts at Bloomberg have recently recommended buying Labcorp Holdings (LH) and Abivax SA Sponsored ADR (ABVX). Both companies have received a Strong Buy consensus rating, with Labcorp Holdings having a $297.08 average price target representing a 6.9% upside, and Abivax SA Sponsored ADR with a $87.17 price target.Labcorp Holdings, a healthcare diagnostics company, has shown significant growth potential. The company has focused on strategic acquisitions and partnerships to drive revenue growth. In the second quarter of 2025, Labcorp invested $25 million in acquisitions and partnerships, contributing 3.5% to revenue growth. The company has also made notable acquisitions such as Incyte Diagnostics and BioReference Health, which have enhanced its capabilities in key specialty areas like oncology and women's health [1].
Labcorp's operational efficiency initiatives, such as the LaunchPad program, have also contributed to its financial performance. The company has successfully achieved targeted savings of $350 million by the end of 2024 and aims to drive $100-$125 million in savings each year [1].
Abivax SA Sponsored ADR, a biotechnology company, has also received a positive outlook from analysts. LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Abivax SA Sponsored ADR with a price target of $116.00. The company's shares closed last Friday at $77.28, indicating a potential for growth [2].
Both companies have experienced bullish sentiments from analysts, suggesting they are well-positioned for future growth. Investors should closely monitor these companies for potential opportunities.
References:
[1] https://www.nasdaq.com/articles/it-right-time-hold-labcorp-stock-your-portfolio
[2] https://www.theglobeandmail.com/investing/markets/stocks/LH/pressreleases/34385440/analysts-offer-insights-on-healthcare-companies-labcorp-holdings-lh-and-abivax-sa-sponsored-adr-abvx/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet